Brief: Hemcheck Q1 Loss After Financial Items Narrows To SEK 3.1 Mln

Bio Vitos Pharma AB

09/05/2023 08:13

May 9 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * Q1 OPERATING INCOME AMOUNTED TO SEK 525,555 (218,567)
    * Q1 LOSS AFTER FINANCIAL ITEMS SEK 3.1 MILLION VERSUS LOSS
SEK
3.9 MILLION YEAR AGO

Source text for Eikon:  ID:nWkr9DvkYy 
Further company coverage:  HEMC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))